Table 4.
Group 1 | Group 2 | Group 3 | Total | ||||||
---|---|---|---|---|---|---|---|---|---|
Nb | % | Nb | % | Nb | % | Nb | % | ||
Complications | 10 | 62.5 | 1 | 20.0 | 0 | 11 | 40.7 | ||
Conversion | 0 | 0 | 1 | 16.7 | 1 | 3.7 | |||
Re-operation | 3 | 18.8 | 1 | 20.0 | 0 | 4 | 14.8 | ||
Clavien-Dindo Mastectomy | 0 | 6 | 37.5 | 4 | 80.0 | 6 | 100 | 16 | 59.3 |
1 | 4 | 25.0 | 0 | 0 | 4 | 14.8 | |||
2 | 3 | 18.8 | 0 | 0 | 3 | 11.1 | |||
3 | 3 | 18.8 | 1 | 20.0 | 0 | 4 | 14.8 | ||
Type complication | Infection | 3 | 18.75 | 1 | 20.0 | 0 | 4 | 14.8 | |
Hematoma | 2 | 12.5 | 1 | 20.0 | 0 | 3 | 11.1 | ||
Skin necrosis | 1 | 6.25 | 0 | 0 | 1 | 3.7 | |||
Lymphocele | 9 | 56.25 | 1 | 20.0 | 0 | 10 | 37.0 | ||
Explantation implant | 2 | 12.5 | 1 | 20.0 | 0 | 3 | 30.0* | ||
Skin blistering | 5 | 31.25 | 0 | 0 | 5 | 18.5 |
*3/10 breast implant